We examined the association between vulnerability to financial exploitation and thickness of a brain region called the ...

For years, scientists have focused on amyloid beta buildup as the main culprit in Alzheimer’s disease, but a new study suggests the real problem might lie in a stalled protein-cutting process in the ...

Researchers are experimenting with memory-based activities as a way to treat Alzheimer's, saying it can boost cognitive neurons needed to fight the disease.

Pioneering musicians are trialling a radical approach that takes treatment beyond medicine – and could save the NHS millions ...

Two new medications, called lecanemab and donanemab, have shown success in clinical trials in slowing down Alzheimer’s disease. These are known as disease-modifying treatments and have been licensed ...

A new blood test is being trialed in the UK to detect the early signs of dementia. It is hoped it could identify patients ...

A major boost in the fight against Alzheimer’s disease and other neurodegenerative disorders is underway, thanks to a $3,027,155 NIH grant awarded to a team of researchers at Central Michigan ...

A new study from Cedars-Sinai suggests that some people diagnosed with behavioral-variant frontotemporal dementia (bvFTD) ...

Several medicines are poised to reach new heights after winning key endorsements from European drug regulators. | Among those ...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and (Nasdaq: BIIB, Corporate headquarters: Cambridge, ...

A doctor says a common ear problem associated with getting older is linked to dementia and can be treated. Dr Anelyssa ...